Rexon Laboratories Limited, a active public limited company, was established on 05 July 1995 in Jalandhar, Punjab, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U51909PB1995PLC016718. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹1.41 Cr.
It upholds a compliant status. Its leadership includes Pankaj Sharma (Director), Karan Sharma (Director), Rakesh Sharma (Managing Director). Past directors included Ashok Sikka, Madhu Sikka, Karan Sharma. It holds ₹40.45 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D5 Sports & Surgicalcomplex Kapurthala Road, Jalandhar, Punjab.
U51909PB1995PLC016718
016718
05 July 1995
₹3.50 Cr
₹1.41 Cr
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Rexon Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Sharma | Director | 06 Feb 2000 | Current |
| Karan Sharma | Director | 05 Jan 2019 | Current |
| Rakesh Sharma | Managing Director | 05 Jul 1995 | Current |
| Vijay Bharat | Director | 29 Sep 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Dec 2008 | Past |
| Pramod Abcsdd | Director | 03 Dec 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 Apr 2020 | Past |
| Pramod Abcsdd | Director | 11 Jun 2018 | Past |
| Pramod Abcsdd | Director | 29 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rexon Laboratories Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.86% decrease. The company also saw a substantial fall in profitability, with a 378.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Rexon Laboratories had a promoter holding of 73.16% and a public holding of 26.84%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹404,538,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2021 | Others | ₹1.00 Cr | Open |
| 15 Jul 2020 | Others | ₹1.50 Cr | Open |
| 02 Jul 2020 | Others | ₹5.50 M | Open |
| 20 Apr 2020 | Others | ₹1.00 M | Open |
| 20 Apr 2020 | Others | ₹1.90 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rexon Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rexon Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexon Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rexon Laboratories Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Rexon Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was completed.
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100452565 was registered on 30 Mar 2021. was recorded as a recent event.
The activity A charge with Others of Rs. 8.00 Cr registered on 28 Oct 1996 with Charge ID 90173366 was modified on 30 Mar 2021. was completed.
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100370343 was registered on 15 Jul 2020. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.55 Cr with Charge ID 100368379 was registered on 02 Jul 2020. was completed.
The CIN of Rexon Laboratories Limited is U51909PB1995PLC016718.
Rexon Laboratories Limited is headquartered at D5 Sports & Surgicalcomplex Kapurthala Road, Jalandhar, Punjab.
Rexon Laboratories Limited was incorporated on 05 July 1995.
The current directors of Rexon Laboratories Limited are
The primary industry of Rexon Laboratories Limited is Manufacturing.
Rexon Laboratories Limited is unlisted.
The authorized capital of Rexon Laboratories Limited is ₹3.50 Cr, and the paid-up capital is ₹1.41 Cr.
The compliance status of Rexon Laboratories Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX